Palbociclib in solid tumor patients with genomic alterations in the cyclin D-CDK4/6-INK4a-Rb pathway: Results from NCI-COG pediatric MATCH trial Arm I (APEC1621I). This is an ASCO Meeting Abstract ...

The bank’s research house noted that the government is forming a comprehensive ecosystem partnership with Arm Holdings (Arm), a leading British semiconductor and software design company.